Real-time enrollment status for this ewing sarcoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:34 PM UTC
| NCT Number | NCT03715933 |
| Recruiting Status | Recruiting |
| Condition | Ewing Sarcoma |
| Phase | PHASE1 |
| Target Enrollment | 411 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | September 8, 2026 (Sep 8, 2026) |
As of October 12, 2026: Clinical trial NCT03715933 is currently recruiting participants. This phase1 study for ewing sarcoma is actively seeking new participants at 24 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03715933 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03715933 was last updated Sep 8, 2026 (September 8, 2026). HelloStudys verifies this status automatically.